Diabetes

National Diabetes Month

Each November,AdvaMed® partners with our member companies to raise awareness and highlight medtech’s role in helping patients manage their diabetes and live fuller and better lives.

Diabetes

Medtech’s Role in Improving Diabetes Care

November is National Diabetes Awareness Month, a time to shine a spotlight on one of the most prevalent and pressing health issues of our time: diabetes. This month serves as a critical reminder of the importance of understanding, preventing, and managing diabetes, which affects millions of Americans and their families. Through education, advocacy, and community support,AdvaMed®, our member companies, and our partners aim to raise awareness about diabetes, its risk factors, and the steps individuals can take to live healthier, more fulfilling lives.

AdvaMed® Members and Partners Recognize National Diabetes Month

Diabetes Patient Stories

Patient

Married by Medtech: Natalie’s and James’ Story

Chronic illness hasn’t stopped Natalie and James from pursuing their fairytale, and medtech has ensured as smooth a pursuit as possible.

Patient

Living Fearlessly in the Face of Diabetes

Hannah’s journey with type one diabetes started when she was ten years old. Now she uses a continuous glucose monitoring system, which records blood sugar levels constantly.

Related Reading

News / Diabetes / Digital Health

Dexcom’s Jake Leach Named Chair of AdvaMed’s Diabetes Sector

February 23, 2026

WASHINGTON—AdvaMed, the MedTech Association®, today announced that Jacob “Jake” Leach, President and Chief Executive Officer at Dexcom, will serve as the next chair of theAdvaMed® Diabetes Sector, succeeding Chris Scoggins, Executive Vice President of Diabetes Care at Abbott. TheAdvaMed® Diabetes Sector represents the world’s leading companies producing technology across the spectrum of diabetes care. 

Blog / Diabetes

Partnerships are Key to Promoting Diabetes Care

December 1, 2025

Despite the prevalence of diabetes, millions of people who could benefit from the latest medtech management tools are unserved or underserved. Patients who do receive a diagnosis and access to continuous glucose monitors (CGMs) and insulin pumps face a learning curve and adjustment in their daily routines to achieve their best outcomes.

News / Coverage & Payment / Diabetes / Government & Legislative Affairs / Health Access

AdvaMed® Welcomes Bipartisan, Bicameral Congressional Diabetes Caucus Concerns Over Draft Medicare Competitive Bidding Proposal

November 3, 2025

WASHINGTON—AdvaMed, the world’s largest trade association representing medtech innovators, today welcomed a letter from U.S. Senators Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.), co-chairs of the Senate Diabetes Caucus, and U.S. Representatives Diana DeGette (D-Colo.-01) and Gus Bilirakis (R-Fla.-12), co-chairs of the U.S. House Diabetes Caucus, to Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz urging the agency not to finalize a proposal the lawmakers warned could reduce and complicate patient access to continuous glucose monitors (CGMs) and durable insulin pumps.
View All

Search